Inflammation Clinical Trial
Official title:
Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass (ProCard): an Observational Pilot Study
This study evaluates the effect of heart-lung bypass on babies undergoing cardiac surgery.
The investigators want to learn more about the inflammation that exposure to bypass creates
in the body by studying markers of inflammation and cell injury in the bloodstream.
Additionally, the investigators want to examine if these markers can predict which babies
develop post-surgical complications. The hypothesis is that babies who undergo bypass will
have higher levels of these markers than babies not exposed to bypass and that these markers
will correlate with how the baby does clinically after surgery.
This study will evaluate markers via blood sampling in babies with congenital heart disease
who do not undergo cardiac surgery, those that undergo surgery without bypass, and those that
undergo surgery with bypass. The overall goal is that this study will lead to useful
biomarkers and lay the groundwork for future novel therapies aimed at improving outcomes for
babies who require heart-lung bypass.
This is a minimal risk observational study looking at markers of inflammation and cell injury
in the bloodstream of babies with congenital heart disease, with a particular emphasis on
whether these markers can predict low cardiac output syndrome in infants who undergo
heart-lung bypass. Low cardiac output syndrome is a common postoperative complication marked
by poor blood flow to the body affecting nearly 1/3 of infants post-bypass and is associated
with significant morbidity and mortality.
Babies not requiring surgery will serve as the control group. Infants in group 1 will have
0.5 ml of blood drawn prior to discharge. This will be scavenged from the laboratory when
possible. Infants in groups 2 and 3 will require serial blood draws over peri-operative time
points each in the volume of 0.5 ml.
Group 2:
T0 = Before surgery (in the OR) T1 = After chest closure or end of case (in the OR) T2 = On
admission to the pediatric intensive care unit T3 = Timed 4-6 hours after the time of
admission T4 = Timed 12 hours (+/- 1 hour) after the time of admission T5 = Timed 24 hours
(+/-1 hour) after the time of admission
Group 3:
T0 =Pre-cardiopulmonary bypass to be obtained in the operating room just prior to surgery T1
= After going on bypass (but prior to modified ultrafiltration) T2 = After modified
ultrafiltration T3 = On admission to the pediatric intensive care unit T4 = Timed 4-6 hours
after the time of admission T5 = Timed 12 hours (+/- 1 hour) after the time of admission T6 =
Timed 24 hours (+/-1 hour) after the time of admission
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03995979 -
Inflammation and Protein Restriction
|
N/A | |
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT03577223 -
Egg Effects on the Immunomodulatory Properties of HDL
|
N/A | |
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Completed |
NCT06216015 -
Exercise Training and Kidney Transplantation
|
N/A | |
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05529693 -
Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population
|
N/A | |
Recruiting |
NCT05670301 -
Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT06065241 -
Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.
|
N/A | |
Completed |
NCT05864352 -
The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
|
||
Completed |
NCT03318731 -
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
|
N/A | |
Not yet recruiting |
NCT06134076 -
Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota
|
N/A | |
Not yet recruiting |
NCT05910489 -
Micro and Nanoplastics in Greenhouse Workers: Biomarkers of Exposure and Effect
|